When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

Multiple Sclerosis MS is an autoimmune condition that can remain undetected for years A doctor explains how long MS can stay ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

A new study published in the journal PNAS by researchers at the Department of Clinical Neuroscience, Karolinska Institutet, ...

At first, I couldn’t recall a major traumatic event in my past. But when I examined more deeply, I realized that my early ...

The  (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...

Multiple sclerosis sufferer Braylee Burnett, who turns 18 on Wednesday, learned she can once again resume infusions for her ongoing battle after her insurance company previously had balked at more ...